Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Ming-Wei Ma, MD

Peking University First Hospital
Beijing, Beijing

Degrees M.D.


Work Experience


Peking University First Hospital June 2018 –present


Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Sept 2012- June 2018


Book


Associate editor of «Key Leaders Opinionon Radiotherapywith Immunotargeted Therapies», AME Publishing Company, 2018.


Publications (1st author)








    1. Ma MW, Li HZ, Gao XS, Liu MZ, Yin H, Yang KW, et al. Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients. Curr Oncol. 2022;29(10):7832-41

    2. Ma MW, Gao XS, Lyu F, Gu XB, Yin H, Li HZ, et al. Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients. World J Urol. 2021;39(6):1815-23.

    3. Jing N, Ma MW, Gao XS, Liu JT, Gu XB, Zhang M, et al. Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma. Annals of translational medicine. 2020;8(21):1447.

    4. Ma MW, Gao XS, Yu HL, Qi X, Sun SQ, Wang D. Cordyceps sinensis Promotes the Growth of Prostate Cancer Cells. Nutr Cancer. 2018:1-7.

    5. Ma MW, Gao XS, Gu XB, Xie M, Cui M, Zhang M, et al. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma. World J Surg Oncol. 2018;16(1):172.

    6. Ma M, Zhu H, Zhang C, Sun X, Gao X, Chen G. "Liquid biopsy"-ctDNA detection with great potential and challenges. Annals of translational medicine. 2015;3(16):235.



Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentation(s):